Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$241 Buy
+2
New +$231 ﹤0.01% 636
2025
Q4
Sell
-414
Closed -$34.8K 699
2025
Q3
$34.8K Buy
414
+17
+4% +$1.4K 0.02% 228
2025
Q2
$31.4K Buy
397
+3
+0.8% +$238 0.02% 195
2025
Q1
$35.4K Buy
394
+1
+0.3% +$93 0.03% 205
2024
Q4
$40.4K Buy
+393
New +$40.5K 0.03% 165

Other funds holding MRK

Hurley Capital's MRK Position: Q1 2026 in Review

Hurley Capital opened a new position in Merck (MRK) in Q1 2026: 2 shares worth $241. The stake represents ﹤0.01% of the portfolio and ranks #636 among its holdings. This is a return to the name: Hurley Capital previously reported a position in MRK as recently as Q3 2025.

Hurley Capital first reported a position in MRK in Q4 2024 and has held it in 5 quarters since. The position peaked at $40.4K in Q4 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hurley Capital held 2 shares of Merck worth $241 as of Q1 2026.
  • Merck was a new Hurley Capital position in Q1 2026.
  • Merck made up ﹤0.01% of Hurley Capital's portfolio in Q1 2026, its #636 holding.
  • Hurley Capital first reported a position in Merck in Q4 2024 and has held it in 5 quarters since.
  • Hurley Capital's Merck position peaked at $40.4K in Q4 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.